SK Life Science Labs
Mike Russell is an experienced professional in the field of oncology biology, currently serving as the Director of Oncology Biology at SK Life Science Labs since November 2021. Prior to this role, Mike held various positions at The Janssen Pharmaceutical Companies of Johnson & Johnson from July 2015 to October 2021, including Associate Director of Oncology Translational Research and Principal Scientist in Oncology Translational Research. Mike's educational background includes a Postdoctoral Fellowship at Children's Hospital of Philadelphia, a PhD in Pharmacology from Drexel University College of Medicine, and a Bachelor of Arts in Neuroscience from the University of Delaware.
This person is not in any teams
SK Life Science Labs
SK Life Science Labs, a subsidiary of SK Biopharmaceuticals, is a U.S. biotech company focused on the discovery of transformative medicines through targeted protein degradation (TPD). We discover and develop therapies through precise degradation of disease-causing proteins. Our team takes a target-centric approach through AI enabled target identification. Our core TPD platform, built upon a strong TPD knowledge base, novel E3 ligands & linkers, and machine-learning based ternary complex modeling, is further complemented by a proprietary MOPED™ molecular glue platform. SK Life Science Labs integrates innovative platforms with deep drug-hunting expertise to defeat disease and improve patients’ lives. View our community guidelines here: http://bit.ly/3REsFKU